{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:08:32Z","timestamp":1773212912778,"version":"3.50.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134458","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T18:16:21Z","timestamp":1438193781000},"page":"e0134458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis"],"prefix":"10.1371","volume":"10","author":[{"given":"Joana T.","family":"de Oliveira","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Barros","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Augusto J.","family":"de Matos","sequence":"additional","affiliation":[]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Gerard R.","family":"Rutteman","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"G\u00e4rtner","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"FT Liu","year":"2005","journal-title":"Nature reviews Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fonc.2014.00138","article-title":"Extracellular galectin-3 in tumor progression and metastasis","volume":"4","author":"A Fortuna-Costa","year":"2014","journal-title":"Frontiers in oncology"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drup.2007.04.001","article-title":"The role of galectin-3 in cancer drug resistance","volume":"10","author":"T Fukumori","year":"2007","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.taap.2008.01.009","article-title":"Evidence of galectin-1 involvement in glioma chemoresistance","volume":"229","author":"M Le Mercier","year":"2008","journal-title":"Toxicology and applied pharmacology"},{"issue":"3","key":"ref5","first-page":"661","article-title":"Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells","volume":"7","author":"Y Honjo","year":"2001","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"7\u20139","key":"ref6","first-page":"543","article-title":"Galectin-3 and metastasis","volume":"19","author":"Y Takenaka","year":"2004","journal-title":"Glycoconjugate journal"},{"issue":"7\u20139","key":"ref7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1387\/ijdb.113359jt","article-title":"Sialylation regulates galectin-3\/ligand interplay during mammary tumour progression\u2014a case of targeted uncloaking","volume":"55","author":"JT de Oliveira","year":"2011","journal-title":"The International journal of developmental biology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6","article-title":"Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma","volume":"79","author":"CA Reis","year":"1998","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"K Ohtsubo","year":"2006","journal-title":"Cell"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/glycob\/cwn122","article-title":"Exposure of alpha2,6-sialylated lactosaminic chains marks apoptotic and necrotic death in different cell types","volume":"19","author":"N Malagolini","year":"2009","journal-title":"Glycobiology"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3\u2014a jack-of-all-trades in cancer","volume":"313","author":"AU Newlaczyl","year":"2011","journal-title":"Cancer letters"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/glycob\/cwq103","article-title":"Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis","volume":"20","author":"JT de Oliveira","year":"2010","journal-title":"Glycobiology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N","article-title":"Decreased expression of galectin-3 is associated with progression of human breast cancer","volume":"179","author":"V Castronovo","year":"1996","journal-title":"The Journal of pathology"},{"issue":"2\u20133","key":"ref14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jcpa.2004.02.002","article-title":"Immunohistochemical expression of galectin-3 in canine mammary tumours","volume":"131","author":"YK Choi","year":"2004","journal-title":"Journal of comparative pathology"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0016-5085(97)70010-6","article-title":"Differential expression of galectin 3 and galectin 1 in colorectal cancer progression","volume":"113","author":"X Sanjuan","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002400050164","article-title":"Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer","volume":"27","author":"J Ellerhorst","year":"1999","journal-title":"Urological research"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2007.04.114","article-title":"Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation","volume":"358","author":"H Ahmed","year":"2007","journal-title":"Biochemical and biophysical research communications"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/path.1778","article-title":"Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)","volume":"206","author":"AE Greijer","year":"2005","journal-title":"The Journal of pathology"},{"issue":"35","key":"ref19","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1200\/JCO.2005.02.0206","article-title":"Galectin-1: a link between tumor hypoxia and tumor immune privilege","volume":"23","author":"QT Le","year":"2005","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1359\/jbmr.070620","article-title":"HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc","volume":"22","author":"Y Zeng","year":"2007","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"1\u20132","key":"ref21","first-page":"15","article-title":"Immunocytochemical analysis for differential diagnosis of thyroid lesions using liquid-based cytology","volume":"73","author":"K Hashimoto","year":"2011","journal-title":"Nagoya journal of medical science"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0002-9440(10)64959-0","article-title":"Galectin-3 induces endothelial cell morphogenesis and angiogenesis","volume":"156","author":"P Nangia-Makker","year":"2000","journal-title":"The American journal of pathology"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1111\/j.1742-4658.2007.05851.x","article-title":"Tumor suppressor p16INK4a\u2014modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells","volume":"274","author":"S Andre","year":"2007","journal-title":"The FEBS journal"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jcb.21159","article-title":"Tumor microenvironment: the role of the tumor stroma in cancer","volume":"101","author":"H Li","year":"2007","journal-title":"Journal of cellular biochemistry"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1476-5829.2008.00163.x","article-title":"The role of hypoxia in canine cancer","volume":"6","author":"SA Snyder","year":"2008","journal-title":"Veterinary and comparative oncology"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/gm271","article-title":"Gene expression and hypoxia in breast cancer","volume":"3","author":"E Favaro","year":"2011","journal-title":"Genome medicine"},{"issue":"1","key":"ref27","first-page":"a008821","article-title":"Autophagy and cancer","volume":"4","author":"LY Mah","year":"2012","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2010.09.064","article-title":"Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain","volume":"1366","author":"OI Ndubuizu","year":"2010","journal-title":"Brain research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2407-8-362","article-title":"Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas","volume":"8","author":"IM Bachmann","year":"2008","journal-title":"BMC cancer"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/fon.11.99","article-title":"The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review","volume":"7","author":"CH Richards","year":"2011","journal-title":"Future oncology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00795-013-0013-4","article-title":"Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ","volume":"46","author":"MJ Rego","year":"2013","journal-title":"Medical molecular morphology"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/glycob\/12.2.129","article-title":"Galectin-3 is strongly up-regulated in nonapoptosing mammary epithelial cells during rat mammary gland involution","volume":"12","author":"J Mengwasser","year":"2002","journal-title":"Glycobiology"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02877054","article-title":"Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines","volume":"28A","author":"E Hellmen","year":"1992","journal-title":"In vitro cellular & developmental biology: journal of the Tissue Culture Association"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.bjc.6601260","article-title":"GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON","volume":"89","author":"PJ Hoskin","year":"2003","journal-title":"British journal of cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-11-167","article-title":"Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4","volume":"11","author":"SE Rademakers","year":"2011","journal-title":"BMC cancer"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbrc.2005.10.033","article-title":"Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer","volume":"338","author":"P Lukyanov","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbagen.2009.07.005","article-title":"Dynamics of galectin-3 in the nucleus and cytoplasm","volume":"1800","author":"KC Haudek","year":"2010","journal-title":"Biochimica et biophysica acta"},{"issue":"7\u20139","key":"ref38","first-page":"527","article-title":"Extracellular functions of galectin-3","volume":"19","author":"J Ochieng","year":"2004","journal-title":"Glycoconjugate journal"},{"issue":"3","key":"ref39","first-page":"584","article-title":"Blood flow in six human melanoma xenograft lines with different growth characteristics","volume":"52","author":"H Lyng","year":"1992","journal-title":"Cancer research"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(06)70684-3","article-title":"WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus","volume":"7","author":"HJ Schunemann","year":"2007","journal-title":"The Lancet infectious diseases"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2009.12.024","article-title":"Galectin-3 contributes to neonatal hypoxic-ischemic brain injury","volume":"38","author":"C Doverhag","year":"2010","journal-title":"Neurobiology of disease"},{"issue":"25","key":"ref42","doi-asserted-by":"crossref","first-page":"21995","DOI":"10.1074\/jbc.C100177200","article-title":"Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway","volume":"276","author":"V Srinivas","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cmet.2005.05.002","article-title":"Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation","volume":"1","author":"JK Brunelle","year":"2005","journal-title":"Cell metabolism"},{"issue":"16","key":"ref44","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1128\/MCB.00060-08","article-title":"Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia","volume":"28","author":"AA Qutub","year":"2008","journal-title":"Molecular and cellular biology"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4161\/cc.10.15.16585","article-title":"Cancer cells metabolically &quot;fertilize&quot; the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors","volume":"10","author":"UE Martinez-Outschoorn","year":"2011","journal-title":"Cell cycle"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1074\/jbc.M107668200","article-title":"Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest","volume":"277","author":"T Yoshii","year":"2002","journal-title":"The Journal of biological chemistry"},{"issue":"18","key":"ref47","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1074\/jbc.M200154200","article-title":"Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation","volume":"277","author":"F Yu","year":"2002","journal-title":"The Journal of biological chemistry"},{"issue":"21","key":"ref48","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1158\/1078-0432.CCR-05-0981","article-title":"Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells","volume":"11","author":"SJ Kwon","year":"2005","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"3\u20134","key":"ref49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10555-007-9095-6","article-title":"Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway","volume":"26","author":"S Nakahara","year":"2007","journal-title":"Cancer metastasis reviews"},{"issue":"45","key":"ref50","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1038\/sj.onc.1207997","article-title":"Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3","volume":"23","author":"S Califice","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"e42699","DOI":"10.1371\/journal.pone.0042699","article-title":"Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling","volume":"7","author":"S Song","year":"2012","journal-title":"PloS one"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.molcel.2007.07.031","article-title":"The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop","volume":"27","author":"S Ramasamy","year":"2007","journal-title":"Molecular cell"},{"issue":"39","key":"ref53","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1038\/onc.2012.478","article-title":"MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors","volume":"32","author":"S Kitamoto","year":"2013","journal-title":"Oncogene"},{"issue":"14","key":"ref54","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1158\/0008-5472.CAN-08-4905","article-title":"MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression","volume":"69","author":"S Aubert","year":"2009","journal-title":"Cancer research"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"DM Brizel","year":"1997","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"19","key":"ref56","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"M Hockel","year":"1996","journal-title":"Cancer research"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/MCB.02236-05","article-title":"Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization","volume":"26","author":"X Zheng","year":"2006","journal-title":"Molecular and cellular biology"},{"key":"ref58","article-title":"Comparative Oncology","author":"AI Baba","year":"2007","journal-title":"Bucharest"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.yexcr.2006.11.005","article-title":"Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin","volume":"313","author":"TA Baptiste","year":"2007","journal-title":"Experimental cell research"},{"issue":"5","key":"ref60","first-page":"2211","article-title":"Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors","volume":"34","author":"DEO JT","year":"2014","journal-title":"Anticancer research"},{"issue":"5","key":"ref61","first-page":"853","article-title":"Galectin-3: a novel protein in cerebellar hemangioblastoma","volume":"6","author":"S Al-Salam","year":"2013","journal-title":"International journal of clinical and experimental pathology"},{"issue":"620","key":"ref62","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1259\/0007-1285-52-620-650","article-title":"Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation","volume":"52","author":"JM Brown","year":"1979","journal-title":"The British journal of radiology"},{"issue":"24","key":"ref63","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1158\/0008-5472.CAN-06-2056","article-title":"Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies","volume":"66","author":"P Martinive","year":"2006","journal-title":"Cancer research"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12307-008-0003-6","article-title":"Regulation of tumor progression by extracellular galectin-3","volume":"1","author":"P Nangia-Makker","year":"2008","journal-title":"Cancer microenvironment: official journal of the International Cancer Microenvironment Society"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1021\/bk-2012-1115.ch011","article-title":"Dynamic Tuning of Galectins and Their Binding Sites During Mammary Tumor Progression and Metastasis","author":"JTd Oliveira","year":"2012","journal-title":"Galectins and Disease Implications for Targeted Therapeutics: American Chemical Society"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10549-011-1919-y","article-title":"A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer","volume":"132","author":"AJ Montero","year":"2012","journal-title":"Breast cancer research and treatment"},{"key":"ref67","author":"JTd Oliveira","year":"2013"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:53:52Z","timestamp":1540029232000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134458"}},"subtitle":[],"editor":[{"given":"Tiffany","family":"Seagroves","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}